BioSpace News Archive

QIAGEN announced that it welcomed the U.S. Preventive Services Task Force reaffirming a previously issued recommendation for latent tuberculosis infection screening by primary care physicians in populations at increased risk.

Eli Lilly and Company announced positive results of the TRAILBLAZER-ALZ 2 Phase 3 study showing that donanemab significantly slowed cognitive and functional decline in people with early symptomatic Alzheimer’s disease.

United Therapeutics Corporation, a public benefit corporation, announced its financial results for the quarter ended March 31, 2023.

SOPHiA GENETICS, a cloud-native software company in the healthcare space and a leader in data-driven medicine, announced that Unipath Specialty Laboratory Limited, one of the leading diagnostic brands in India, is live on the SOPHiA DDM™ Homologous Recombination Deficiency Solution.

G1 Therapeutics, Inc., a commercial-stage oncology company, provided a corporate and financial update for the first quarter ended March 31, 2023.

Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended March 31, 2023.

Caris Life Sciences®, the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced that the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center has joined the Caris Precision Oncology Alliance™.

EMPOWER CLINICS INC is pleased to announce that its subsidiary EPW Curesearch LLC has signed another Research Services Agreement with a leading physician and researcher who will act as a Principal Investigator supporting the provision of Pharmaceutical Research and Clinical Trials Services of the first site in Dallas, TX.

Merck, known as MSD outside of the United States and Canada, announced that Caroline Litchfield, executive vice president and chief financial officer, is scheduled to participate in a fireside chat at the Bank of America Securities 2023 Healthcare Conference on Wednesday, May 10, 2023, at 8:40 a.m. PDT / 11:40 a.m. EDT.

Cingulate Inc. announced the successful completion of the manufacturing transfer of its lead candidate, CTx-1301, to Societal CDMO, Inc., a bi-coastal contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development.